Best Practice in Systemic Therapy for Head and Neck Squamous Cell Carcinoma

Area of Science:

• Oncology
• Clinical Medicine
• Cancer Research

Background:

• Systemic therapy for head and neck cancer is complex due to tumor, patient, and treatment factors.
• Current treatment paradigms are evolving with new therapeutic agents.

Purpose of the Study:

• To review the standard of care for head and neck cancer systemic therapy in curative and palliative settings.
• To outline best practices for treatment delivery, monitoring, and outcome assessment.

Main Methods:

• Literature review summarizing current evidence and expert consensus.
• Focus on multidisciplinary team approach, drug choices, and toxicity management.

Main Results:

• Cisplatin remains a cornerstone in chemoradiotherapy and induction chemotherapy, despite significant toxicity.
• Checkpoint inhibitors show promise in metastatic settings, altering treatment strategies.
• Effective management of adverse events is crucial for patient safety and treatment adherence.

Conclusions:

• Multidisciplinary team discussion is essential for personalized head and neck cancer treatment planning.
• Vigilant monitoring and management of toxicity are paramount for successful systemic therapy.
• Data documentation and participation in quality initiatives drive best practice implementation.